These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 32329357)

  • 21. Clinical and Lifestyle Factors and Risk of Amyotrophic Lateral Sclerosis: A Population-Based Case-Control Study.
    Filippini T; Fiore M; Tesauro M; Malagoli C; Consonni M; Violi F; Arcolin E; Iacuzio L; Oliveri Conti G; Cristaldi A; Zuccarello P; Zucchi E; Mazzini L; Pisano F; Gagliardi I; Patti F; Mandrioli J; Ferrante M; Vinceti M
    Int J Environ Res Public Health; 2020 Jan; 17(3):. PubMed ID: 32019087
    [No Abstract]   [Full Text] [Related]  

  • 22. Prevalence of amyotrophic lateral sclerosis - United States, 2010-2011.
    Mehta P; Antao V; Kaye W; Sanchez M; Williamson D; Bryan L; Muravov O; Horton K; ;
    MMWR Suppl; 2014 Jul; 63(7):1-14. PubMed ID: 25054277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of environmental mercury, lead and pesticide exposure in development of amyotrophic lateral sclerosis.
    Johnson FO; Atchison WD
    Neurotoxicology; 2009 Sep; 30(5):761-5. PubMed ID: 19632272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Level of neurotoxic metals in amyotrophic lateral sclerosis: A population-based case-control study.
    Bocca B; Forte G; Oggiano R; Clemente S; Asara Y; Peruzzu A; Farace C; Pala S; Fois AG; Pirina P; Madeddu R
    J Neurol Sci; 2015 Dec; 359(1-2):11-7. PubMed ID: 26671079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Occupation and amyotrophic lateral sclerosis risk: a case-control study in the isolated island population of Malta.
    Farrugia Wismayer M; Borg R; Farrugia Wismayer A; Bonavia K; Vella M; Pace A; Vassallo N; Cauchi RJ
    Amyotroph Lateral Scler Frontotemporal Degener; 2021 Nov; 22(7-8):528-534. PubMed ID: 33821701
    [No Abstract]   [Full Text] [Related]  

  • 26. Preliminary Results of National Amyotrophic Lateral Sclerosis (ALS) Registry Risk Factor Survey Data.
    Bryan L; Kaye W; Antao V; Mehta P; Muravov O; Horton DK
    PLoS One; 2016; 11(4):e0153683. PubMed ID: 27124833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for amyotrophic lateral sclerosis: A regional United States case-control study.
    Andrew AS; Bradley WG; Peipert D; Butt T; Amoako K; Pioro EP; Tandan R; Novak J; Quick A; Pugar KD; Sawlani K; Katirji B; Hayes TA; Cazzolli P; Gui J; Mehta P; Horton DK; Stommel EW
    Muscle Nerve; 2021 Jan; 63(1):52-59. PubMed ID: 33006184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Environmental exposure to trace elements and risk of amyotrophic lateral sclerosis: a population-based case-control study.
    Bergomi M; Vinceti M; Nacci G; Pietrini V; Brätter P; Alber D; Ferrari A; Vescovi L; Guidetti D; Sola P; Malagu S; Aramini C; Vivoli G
    Environ Res; 2002 Jun; 89(2):116-23. PubMed ID: 12123644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood levels of trace metals and amyotrophic lateral sclerosis.
    Peters TL; Beard JD; Umbach DM; Allen K; Keller J; Mariosa D; Sandler DP; Schmidt S; Fang F; Ye W; Kamel F
    Neurotoxicology; 2016 May; 54():119-126. PubMed ID: 27085208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Amyotrophic lateral sclerosis and mercury--preliminary report].
    Mano Y; Takayanagi T; Abe T; Takizawa Y
    Rinsho Shinkeigaku; 1990 Nov; 30(11):1275-7. PubMed ID: 2085936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early life metal dysregulation in amyotrophic lateral sclerosis.
    Figueroa-Romero C; Mikhail KA; Gennings C; Curtin P; Bello GA; Botero TM; Goutman SA; Feldman EL; Arora M; Austin C
    Ann Clin Transl Neurol; 2020 Jun; 7(6):872-882. PubMed ID: 32438517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medical history of chemotherapy or immunosuppressive drug treatment and risk of amyotrophic lateral sclerosis (ALS).
    Kuczmarski T; Stommel EW; Riley K; Tandan R; Chaudhry V; Clawson L; Caller TA; Henegan PL; Facciponte DN; Bradley WG; Andrew AS
    J Neurol; 2017 Aug; 264(8):1763-1767. PubMed ID: 28711998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amyotrophic lateral sclerosis and occupational history. A pilot case-control study.
    Strickland D; Smith SA; Dolliff G; Goldman L; Roelofs RI
    Arch Neurol; 1996 Aug; 53(8):730-3. PubMed ID: 8759978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurodegenerative and psychiatric diseases among families with amyotrophic lateral sclerosis.
    Longinetti E; Mariosa D; Larsson H; Ye W; Ingre C; Almqvist C; Lichtenstein P; Piehl F; Fang F
    Neurology; 2017 Aug; 89(6):578-585. PubMed ID: 28701495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Essential trace elements in amyotrophic lateral sclerosis (ALS): Results in a population of a risk area of Italy.
    Forte G; Bocca B; Oggiano R; Clemente S; Asara Y; Sotgiu MA; Farace C; Montella A; Fois AG; Malaguarnera M; Pirina P; Madeddu R
    Neurol Sci; 2017 Sep; 38(9):1609-1615. PubMed ID: 28601974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Environmental risk factors and amyotrophic lateral sclerosis (ALS): A case-control study of ALS in China.
    Lian L; Liu M; Cui L; Guan Y; Liu T; Cui B; Zhang K; Tai H; Shen D
    J Clin Neurosci; 2019 Aug; 66():12-18. PubMed ID: 31155341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Serum Retinol-Binding Protein 4 Concentration With Risk for and Prognosis of Amyotrophic Lateral Sclerosis.
    Rosenbohm A; Nagel G; Peter RS; Brehme T; Koenig W; Dupuis L; Rothenbacher D; Ludolph AC;
    JAMA Neurol; 2018 May; 75(5):600-607. PubMed ID: 29482216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of risk factors associated with onset and progression of amyotrophic lateral sclerosis using systematic review and meta-analysis.
    Wang MD; Little J; Gomes J; Cashman NR; Krewski D
    Neurotoxicology; 2017 Jul; 61():101-130. PubMed ID: 27377857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Associations of Electric Shock and Extremely Low-Frequency Magnetic Field Exposure With the Risk of Amyotrophic Lateral Sclerosis.
    Peters S; Visser AE; D'Ovidio F; Beghi E; Chiò A; Logroscino G; Hardiman O; Kromhout H; Huss A; Veldink J; Vermeulen R; van den Berg LH;
    Am J Epidemiol; 2019 Apr; 188(4):796-805. PubMed ID: 30649156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is exposure to cyanobacteria an environmental risk factor for amyotrophic lateral sclerosis and other neurodegenerative diseases?
    Bradley WG; Borenstein AR; Nelson LM; Codd GA; Rosen BH; Stommel EW; Cox PA
    Amyotroph Lateral Scler Frontotemporal Degener; 2013 Sep; 14(5-6):325-33. PubMed ID: 23286757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.